Literature DB >> 16971182

Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions.

Edwin Michael1, Mwele N Malecela-Lazaro, Bertha T A Maegga, Peter Fischer, James W Kazura.   

Abstract

Monitoring and evaluation are crucially important to the scientific management of any mass parasite control programme. Monitoring enables the effectiveness of implemented actions to be assessed and necessary adaptations to be identified; it also determines when management objectives are achieved. Parasite transmission models can provide a scientific template for informing the optimal design of such monitoring programmes. Here, we illustrate the usefulness of using a model-based approach for monitoring and evaluating anti-parasite interventions and discuss issues that need addressing. We focus on the use of such an approach for the control and/or elimination of the vector-borne parasitic disease, lymphatic filariasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971182     DOI: 10.1016/j.pt.2006.08.011

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  18 in total

1.  Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa.

Authors:  H Joseph; F Maiava; T Naseri; U Silva; P Lammie; W Melrose
Journal:  Ann Trop Med Parasitol       Date:  2011-12

2.  Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.

Authors:  Daniel J Tisch; Moses J Bockarie; Zachary Dimber; Benson Kiniboro; Nandao Tarongka; Fred E Hazlett; Will Kastens; Michael P Alpers; James W Kazura
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

3.  Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Authors:  Paul E Simonsen; Erling M Pedersen; Rwehumbiza T Rwegoshora; Mwelecele N Malecela; Yahya A Derua; Stephen M Magesa
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

4.  Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.

Authors:  Brajendra K Singh; Moses J Bockarie; Manoj Gambhir; Peter M Siba; Daniel J Tisch; James Kazura; Edwin Michael
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone.

Authors:  Mary H Hodges; Mustapha Sonnie; Hamid Turay; Abdulai Conteh; Florence Maccarthy; Santigie Sesay
Journal:  Parasit Vectors       Date:  2012-10-12       Impact factor: 3.876

6.  Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes.

Authors:  Edwin Michael; Mwele N Malecela; Mihail Zervos; James W Kazura
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

7.  Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.

Authors:  Manoj Gambhir; Edwin Michael
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

8.  What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.

Authors:  Randee J Kastner; Christopher M Stone; Peter Steinmann; Marcel Tanner; Fabrizio Tediosi
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09

9.  Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.

Authors:  Paul E Simonsen; Yahya A Derua; William N Kisinza; Stephen M Magesa; Mwele N Malecela; Erling M Pedersen
Journal:  BMC Infect Dis       Date:  2013-07-21       Impact factor: 3.090

10.  Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.

Authors:  Brian K Chu; Michael Deming; Nana-Kwadwo Biritwum; Windtaré R Bougma; Améyo M Dorkenoo; Maged El-Setouhy; Peter U Fischer; Katherine Gass; Manuel Gonzalez de Peña; Leda Mercado-Hernandez; Dominique Kyelem; Patrick J Lammie; Rebecca M Flueckiger; Upendo J Mwingira; Rahmah Noordin; Irene Offei Owusu; Eric A Ottesen; Alexandre Pavluck; Nils Pilotte; Ramakrishna U Rao; Dilhani Samarasekera; Mark A Schmaedick; Sunil Settinayake; Paul E Simonsen; Taniawati Supali; Fasihah Taleo; Melissa Torres; Gary J Weil; Kimberly Y Won
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.